A- A A+

HIV transmission is still a major concern in Europe, in particular in the eastern part of the WHO European Region.

In 2015, more than 153 000 people were diagnosed with HIV, the highest number of newly diagnosed infections ever reported in one year. Of these, 79% were diagnosed in the East of the Region and 19% in the European Union and European Economic Area (EU/EEA). Newly diagnosed infections from Russia represented 64% of all cases in the WHO European Region and 81% of cases in the East of the Region. 

The data presented in this report indicate that, despite significant efforts dedicated to the prevention and control of HIV in Europe, the number of new HIV diagnoses has not declined substantially over the last decade in the western part of the Region and the EU/EEA, and has more than doubled in the East. In the Centre, while remaining at a low level overall, the number of new diagnoses has increased more than anywhere else in the Region. (WHO, Regional Office for Europe, November 2016)


Factors associated with HIV testing among male injecting drug users: findings from a cross-sectional behavioural and biological survey in Manipur and Nagaland, India

Deepika Ganju, Sowmya Ramesh and Niranjan Saggurti

Harm Reduction Journal201613:21

DOI: 10.1186/s12954-016-0110-5


Factors associated with the uptake of and adherence to HIV pre-exposure prophylaxis in people who have injected drugs: an observational, open-label extension of the Bangkok Tenofovir Study

Martin, Michael et al.

The Lancet HIV , Volume 4 , Issue 2 , e59 - e66



Improved quality of life with immediate initiation of antiretroviral therapy in the strategic timing of antiretroviral therapy trial.

Lifson AR, Grund B, Gardner EM, Kaplan R, Denning E, Engen N, Carey CL, Chen F, Dao S, Florence E, Sanz J, Emery S; INSIGHT START Study Group..

AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001417. [Epub ahead of print]



BANGKOK, 24 January 2017—The Joint United Nations Programme on HIV/AIDS (UNAIDS) and the AIDS Data Hub, a regional data analysis team, have launched a mobile application called AIDSDataHub. The app features strategic information including UNAIDS Snapshots: HIV epidemic in Asia and the Pacific which is an interactive report with links to videos, colourful infographics and bite-size information on the HIV epidemic and response in countries, as well as on key populations at higher risk of HIV in Asia and the Pacific.


“We need a data revolution in order to have the right information to track the progress countries are making towards the Fast-Track targets,” said Steve Kraus, Director of the UNAIDS Regional Support Team for Asia and the Pacific. “The AIDSDataHub app supports researchers, government and civil society programme managers by providing a comprehensive set of accurate information on a regular basis.”

The app can be downloaded for free through the Apple store or Google Play. Many of the  graphs and visuals contain key messages, which support evidence-informed solutions and can help with Fast-Track advocacy efforts. (UNAIDS Bagkok - Data Hub Evidence To Action, 25.01.2017)


Seit kurzem werden sogenannte breit-neutralisierende Antikörper bei Patienten mit einer HIV-Infektion experimentell eingesetzt. Das Forscherteam um Prof. Dr. Florian Klein, Uniklinik Köln und Deutsches Zentrum für Infektionsforschung (DZIF), hat einen neuen HIV neutralisierenden Antikörper nun erstmals im Menschen untersucht. Die Studie, die in enger Kooperation mit der Rockefeller University in New York durchgeführt wurde, ist jüngst in dem renommierten Wissenschaftsmagazin Nature Medicine veröffentlicht worden. (Deutsches Zentrum für Infektionsforschung (DZIF), 17.01.2017)


Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial

O'Connor, Jemma et al.

The Lancet HIV , Volume 0 , Issue 0 ,


Psychiatric and Substance use Disorders in HIV/Hepatitis C Virus (HCV)-Coinfected Patients

Does HCV Clearance Matter? (Agence Nationale de Recherche sur le SIDA et les Hepatites Virales (ANRS) HEPAVIH CO13 Cohort)

L Michel; C Lions; M Winnock; J-P Lang; M-A Loko; E Rosenthal; B Marchou; M-A Valantin; P Morlat; P Roux; P Sogni; B Spire; I Poizot-Martin; K Lacombe; C Lascoux-Combe; C Duvivier; D Neau; F Dabis; D Salmon-Ceron; MP Carrieri

HIV Medicine. 2016;17(10):758-765. 


Die HIV-Präexpositionsprophylaxe (PREP) war das beherrschende Thema des Jahres 2016 - und 2017 wird es wahrscheinlich so bleiben. Deutsche AIDS-Hilfe, 30.12.2016)


Better to know: the importance of early HIV diagnosis

May, Margaret T

The Lancet Public Health , Volume 0 , Issue 0 ,


HIV/Aids, andere sexuell übertragbare Infektionen, Methoden für die Präventionsarbeit vor Ort, aktuelle Studienergebnisse und vieles mehr.


Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort

Croxford, Sara et al.

The Lancet Public Health , Volume 0 , Issue 0 ,


Vital Signs: Trends in HIV Diagnoses, Risk Behaviors, and Prevention Among Persons Who Inject Drugs - United States.

Wejnert C, Hess KL, Hall HI, Van Handel M, Hayes D, Fulton P Jr, An Q, Koenig LJ, Prejean J, Valleroy LA.

MMWR Morb Mortal Wkly Rep. 2016 Dec 2;65(47):1336-1342. doi: 10.15585/mmwr.mm6547e1.


Die neue Ausgabe des Magazins erscheint mit Beiträgen über Frauen zwischen Gesetz und Selbstbestimmung, den Gesundheitstag für Migrantinnen und Diskriminierung in der ärztlichen Praxis. Außerdem Neues vom Netzwerk Frauen und Aids und spannende Buch-Tipps. (DHIVA - Zeitschrift für Frauen zu Sexualität und Gesundheit, Die DHIVA ist ein Projekt der GSSG – Gemeinnützige Stiftung Sexualität und Gesundheit NRW)


Der neue HIVreport mit Studienergebnissen und Hinweisen für die Beratung von MSM mit Sex-und Partydrogenproblemen.


L Rodkjaer; C Gabel; T Laursen; M Slot; P Leutscher; N Christensen; J Holmskov; M Sodemann

HIV Medicine. 2016;17(10):749-757.


This week, an HIV epidemic has been officially declared in the Russian city of Yekaterinburg, where the health department estimates 1 out of every 50 residents is a carrier of the virus. (...)  In May, the head of the state AIDS center said that the country hit a tragic milestone of one million diagnosed HIV cases... (Emma Lantreev, gizmodo.com, 04.11.2016?


Shubber Z, Mills EJ, Nachega JB, Vreeman R, Freitas M, Bock P, et al. (2016) Patient-Reported Barriers to Adherence to Antiretroviral Therapy: A Systematic Review and Meta-Analysis. PLoS Med 13(11): e1002183. doi:10.1371/journal.pmed.1002183


Successful control of a large outbreak of HIV infection associated with injection of cathinone derivatives in Tel Aviv, Israel.

Katchman E, Ben-Ami R, Savyon M, Chemtob D, Avidor B, Wasserman A, Zeldis I, Girshengorn S, Amitai Z, Sheffer R, Turner D.

Clin Microbiol Infect. 2016 Nov 19. pii: S1198-743X(16)30564-X. doi: 10.1016/j.cmi.2016.11.009.



HIV incidence and behavioral correlates of HIV acquisition in a cohort of injection drug users in St Petersburg, Russia.

Kozlov AP, Skochilov RV, Toussova OV, Verevochkin SV, Krasnoselskikh TV, Malov SV, Shaboltas AV.

Medicine (Baltimore). 2016 Nov;95(44):e5238.



Genf – (...) (Die) Weltgesundheitsorganisation (WHO) (hat) anlässlich des Weltaidstages am 1. Dezember ihre Forderung nach Selbsttests bekräftigt – die in Deutschland nach wie vor „illegal“ sind. (aerzteblatt.de, 01.12.2016)



Treatment Action Group is an independent AIDS research and policy think tank fighting for better treatment, a vaccine, and a cure for AIDS.

TAG works to ensure that all people with HIV receive lifesaving treatment, care, and information.

We are science-based treatment activists working to expand and accelerate vital research and effective community engagement with research and policy institutions.

TAG catalyzes open collective action by all affected communities, scientists, and policy makers to end AIDS.


New York – Die Zahl der jährlich neuen HIV-Infektionen unter Jugendlichen könnte nach Schätzungen der Vereinten Nationen im Jahr 2030 bis zu 400.000 betragen. (aerzteblatt.de, 01.12.2016)


Berlin – Die erfolgreiche Präventionsarbeit gegen die Ausbreitung von HIV in Deutsch­land muss weitergehen. Dazu hat die Vizepräsidentin der Bundesärztekammer (BÄK), Martina Wenker, aufgerufen. (aerzteblatt.de, 30.11.2016)


Copenhagen. For the first time, the cumulative number of HIV cases in the WHO European Region increased to over 2 million. More than 153 000 new HIV cases contributed to this figure in 2015 – a 7% increase compared to the previous year and the highest annual number since reporting began in the 1980s. These are the main findings of the new report "HIV/AIDS surveillance in Europe 2015", released jointly by the WHO Regional Office for Europe and the European Centre for Disease Prevention and Control (ECDC) ahead of World AIDS Day 2016. (WHO Regional Office for Europe, 29.11.2016)


(...) Today, there are an estimated 1.5 million people who have been diagnosed with HIV or AIDS in Russia, which has a population of 140 million. (Business Insider, 27.11.2016)


Stockholm – Die Zahl der neu diagnostizierten HIV-Infektionen in Europa ist stabil – doch viele wissen nichts von ihrer Erkrankung. (aerzteblatt.de, 29.11.2016)


Köln. Drei HIV-positive Menschen geben in diesem Jahr der Kampagne zum Welt-AIDS-Tag #positivzusammenleben ihr Gesicht - stellvertretend für alle Menschen mit HIV. Das Bundesministerium für Gesundheit (BMG) und die Bundeszentrale für gesundheitliche Aufklärung (BZgA) führen zusammen mit der Deutschen AIDS-Hilfe und der Deutschen AIDS-Stiftung die Gemeinschaftskampagne #positivzusammenleben durch, um mit Information zu HIV Diskriminierung entgegenzuwirken. (Pressemitteilung der Bundeszentrale für gesundheitliche Aufklärung (BZgA) vom 28.11.2016)